ABC News Correspondent Completes Testicular Cancer Treatment Successfully
Will Reeve completed testicular cancer treatment and achieved cancer-free status.
Event / Science
ABC News correspondent Will Reeve publicly disclosed his diagnosis with embryonal carcinoma (testicular cancer) in April 2026, underwent surgical treatment in May-June, completed chemotherapy in July, and was declared cancer-free by September. He announced his diagnosis publicly in late September to raise awareness and reduce stigma around testicular cancer.
2026-09-30 to 2026-11-01 · UTC publication dates
Coverage begins 30 Sept, 01:48 UTC
Follow the documented timeline or explore the related reporting.
Will Reeve, a 34-year-old correspondent for ABC News reporting on shows including Good Morning America, was diagnosed with testicular cancer in April 2026. He noticed a lump in his left testicle and was encouraged by his wife Amanda to seek medical evaluation. An ultrasound revealed a mass in the testicle.
In July 2026, Will Reeve began chemotherapy treatment at Memorial Sloan Kettering Cancer Center in New York City to reduce the risk of cancer recurrence to nearly 1%. He underwent two cycles of chemotherapy, each lasting two hours, along with cold capping treatment to help prevent hair loss. Side effects included bone pain, ringing ears, night sweats, blood clots and headaches.
In late July 2026, Will Reeve rang the bell at Memorial Sloan Kettering Cancer Center to mark the successful completion of his cancer treatment. By September 8, 2026, he learned during a checkup that he was cancer-free. He continues to have scans and bloodwork three to four times a year to monitor for any recurrence.
On September 29, 2026, Will Reeve announced his testicular cancer diagnosis and treatment journey on ABC's Good Morning America. He disclosed the diagnosis publicly to help destigmatize testicular cancer and raise awareness. He stated he is now cancer-free and emphasized that testicular cancer outcomes are typically positive with early treatment.
In early May 2026, Will Reeve underwent an orchiectomy, a surgical procedure to remove his left testicle due to testicular cancer. The surgery led to a formal diagnosis of embryonal carcinoma, an aggressive form of testicular cancer typically found in young to middle-aged individuals.
In June 2026, Will Reeve underwent a second surgery lasting six hours called retroperitoneal lymph node dissection, during which dozens of lymph nodes were removed to prevent the cancer from spreading. He was hospitalized for almost a week. Three of the removed lymph nodes tested positive for cancer.
Will Reeve completed testicular cancer treatment and achieved cancer-free status.